Fundraising Fox

Nuvation Bio

NYSE: NUVB

New York, US · Incorporated in Delaware · 5 known investors

nuvationbio.com ↗

Nuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.

BiotechHealthtech

Founders & leadership

DH
David HungFounder, President & Chief Executive Officer

Investors · 5

Aisling CapitalNew York
Decheng CapitalMenlo Park
EcoR1 CapitalSan Francisco
Vertex Ventures ChinaSingapore · $2M – $85M
Omega FundsreportedBostonvia Michelle Doig · board

In the news

Nuvation Bio Surges In Global Coverage - Aromatherapy Naturalsaromatherapynaturals.com · Aug 2026Nuvation Bio stock rises after Cantor starts at Overweight By Investing.cominvesting.com · Aug 2026Why is Nuvation Bio stock rallying today? By Investing.cominvesting.com · Aug 2026Nuvation Bio (NUVB) Stock Rises On IBTROZI Growth And Deeper Losses - Simply Wall St Newssimplywall.st · Aug 2026Nuvation Bio raises $287.5M in convertible notes offering By Investing.cominvesting.com · Jul 2026

Frequently asked questions

What does Nuvation Bio do?
Nuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.
Who are Nuvation Bio's investors?
Nuvation Bio's investors include Aisling Capital, Decheng Capital, EcoR1 Capital, Vertex Ventures China, Omega Funds.
Where is Nuvation Bio headquartered?
Nuvation Bio is headquartered in New York, US.